2022
DOI: 10.1016/j.diabet.2022.101370
|View full text |Cite
|
Sign up to set email alerts
|

Smoking and diabetes interplay: A comprehensive review and joint statement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
33
1
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 60 publications
(38 citation statements)
references
References 103 publications
2
33
1
2
Order By: Relevance
“…The significantly raised risk of liver and kidney cancers, and non-significantly raised risks of colorectal, pancreatic and endometrial cancers and non-Hodgkin lymphoma, accord with raised risks of these tumours generally found in type 2 cohorts 1-5 and, with the exception of non-Hodgkin lymphoma, generally also in nominally type 1 cohorts. 5,[8][9][10][11][12] Likewise, the significantly reduced risk of prostate cancer in patients with diabetes diagnosed at older ages in our cohort accords with reduced risk in type 2 diabetes cohorts [1][2][3][4][5] 39 and smoking prevalence 40 Our study of type 1 diabetes patients had several strengths-large size; information to allow analyses by age at diagnosis of diabetes (not published for any other cohort, except for one publication on a twoway split of ages for three cancer sites 10 ); high completeness of follow-up; longer follow-up than any study previously; information on cancer mortality as well as incidence; and restriction to insulin-treated patients. However, it is a weakness that, like most other cohorts, we did not have direct data on diabetes type: for the diabetes onset under age 30 group, the effect should have been minor, since we estimate about 94% will have been type 1, but for the comparison group of patients diagnosed at ages 30 to 49, the effect will have been of greater impact since only about 68% would have been type 2.…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…The significantly raised risk of liver and kidney cancers, and non-significantly raised risks of colorectal, pancreatic and endometrial cancers and non-Hodgkin lymphoma, accord with raised risks of these tumours generally found in type 2 cohorts 1-5 and, with the exception of non-Hodgkin lymphoma, generally also in nominally type 1 cohorts. 5,[8][9][10][11][12] Likewise, the significantly reduced risk of prostate cancer in patients with diabetes diagnosed at older ages in our cohort accords with reduced risk in type 2 diabetes cohorts [1][2][3][4][5] 39 and smoking prevalence 40 Our study of type 1 diabetes patients had several strengths-large size; information to allow analyses by age at diagnosis of diabetes (not published for any other cohort, except for one publication on a twoway split of ages for three cancer sites 10 ); high completeness of follow-up; longer follow-up than any study previously; information on cancer mortality as well as incidence; and restriction to insulin-treated patients. However, it is a weakness that, like most other cohorts, we did not have direct data on diabetes type: for the diabetes onset under age 30 group, the effect should have been minor, since we estimate about 94% will have been type 1, but for the comparison group of patients diagnosed at ages 30 to 49, the effect will have been of greater impact since only about 68% would have been type 2.…”
Section: Discussionsupporting
confidence: 71%
“…The results on risk by duration since diabetes onset in our cohort gave no indication of relations other than for ovarian and vulval cancer risks in patients with diabetes onset before age 30, which reached a peak and then diminished, and lung cancer in patients with diabetes onset at ages 30 and older. The latter diminished consistently with longer follow up, and may indicate selective early mortality of heavy smokers with diabetes (which we estimate based on published data on mortality 39 and smoking prevalence 40 in patients with diabetes might have reduced the proportion of heavy smokers in the denominator by about 40%), and/or younger smoking cessation in patients with diabetes, and hence exceptionally low smoking levels in those surviving to later years. With the exception of two cases of melanoma, there was no indication of raised cancer risk soon after the start of follow up, which could indicate cancer diagnoses as a consequence of clinical workup for diabetes or vice versa.…”
Section: Discussionmentioning
confidence: 78%
“…Similarly, in the United States, diabetes rates are higher in rural areas than in urban areas ( 18 ). Previous studies have also demonstrated that smoking increases the risk of prediabetes and diabetes in the general population ( 19 ). In addition, alcohol abuse is associated with an increased risk of diabetes, while low-to-moderate consumption of wine may have beneficial effects ( 20 ).…”
Section: Discussionmentioning
confidence: 95%
“…It is well known that cigarette smoking is associated with an increased risk of cardiovascular disease, including for patients with T2D. 1,2,21,22 However, in the current study, cigarette smoking was not associated with an increased Differences between smoking statuses were tested using a two-sided Mann-Whitney U test for continuous variables and a x 2 test for categorical variables. Antihypertensives included angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, loop diuretics and beta blockers.…”
Section: Discussionmentioning
confidence: 59%